Concise Analysis of the International Biopharmaceuticals Market
DUBLIN, Ireland, March 6, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/pv574s/biopharmaceuticals) has announced the addition of the "Concise Analysis of the International Biopharmaceuticals Market" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The report reviews, analyses and projects the biopharmaceuticals market (2010-2020) for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - Germany, the United Kingdom, France, Italy, Spain and Russia; Asia-Pacific - Japan, China and India; South America - Argentina and Brazil.
Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and others. Therapeutic areas analyzed include Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and others. Biopharmaceuticals market, estimated at US$199.7 billion globally in 2013, is further projected to reach US$497.9 billion by 2020, growing at 13.5% CAGR between 2010 and 2020. Among different product segments, monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In terms of therapeutic area, neurology applications is the largest market for global biopharmaceuticals with an estimated 2013 share of 28.2% valued at US$56.3 billion, and further expected reach a projected US$144.5 billion by 2020.
The study includes 249 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market by geographic region, product segment and therapeutic area. This study profiles 25 key global players and 70 major players across North America - 24; Europe - 17; Asia-Pacific - 27 and Rest of World - 2. The report also provides the listing of the companies engaged in research and development, manufacturing and supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 492 companies.
Key Topics Covered:
Part A: Global Market Perspective
1. Introduction
2. Key Facts And Figures Of Biopharma Industry And Latest Approvals
3. Key Market Trends
4. Key Global Players
5. Key Business Trends
6. Global Market Overview
Part B: Regional Market Perspective
1. North America
2. Europe
3. Asia-Pacific
4. South America
5. Rest Of World
Part C: Guide To The Industry
1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World
Part D: Annexure
1. Research Methodology
2. The Questionnaire
3. Feedback
Companies Mentioned:
- Abbott Laboratories, Inc.
- Amgen, Inc.
- Astrazeneca PLC
- BASF SE
- Bayer AG
- Biocon Ltd.
- Biogen Idec
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company Limited
- Eli Lilly and Company
- Genentech, Inc.
- Glaxosmithkline, PLC
- Hospira, Inc.
- Johnson & Johnson, Inc.
- LG Life Sciences
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Ranbaxy Laboratories Ltd.
- Roche Holding AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- UCB S.A
For more information visit http://www.researchandmarkets.com/research/pv574s/biopharmaceuticals
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article